IDEXX Laboratories Aktie News

IDEXX Laboratories, Inc. (IDXX) Q4 2025 Earnings Call Transcript

Idexx stock fell early Monday despite beating fourth-quarter expectations and issuing strong guidance for 2026.

Animal diagnostics maker IDEXX Laboratories on Monday forecast 2026 revenue and profit above Wall Street estimates, betting that resilient demand at veterinary clinics and higher testing per visit will offset uneven clinic-visit trends.

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced fourth quarter and full year results. Fourth Quarter and Full Year Results The Company reports revenues of $1,091 million for the fourth quarter of 2025, an increase of 14% compared to the prior year period as reported and 12% on an organic basis, driven by C...

The coming week will put Big Tech earnings and the Federal Reserve firmly in focus, with markets bracing for key signals on growth, inflation, and policy direction.

MoneyShow presents top investment ideas for 2026 from their contributors. This year's edition presents a mix of metals plays, financial stocks, deep value names, high-octane growth and tech stocks, and beaten-down REITs that offer solid income and turnaround potential. Part 5 of this series includes Hormel Foods, IonQ, Kodiak AI, Lara Exploration and MannKind.

WESTBROOK, Maine--(BUSINESS WIRE)--ImageVue DR50 Plus introduces high-definition diagnostic imaging at the lowest dose of radiation, accelerating diagnosis and improving staff safety.

WESTBROOK, Maine--(BUSINESS WIRE)--Cancer Dx Panel expansion and inVue Dx FNA cytology rollout advance veterinary cancer care, enabling comprehensive mast cell tumor testing for dogs.